icon phone
+441792688004
Calls free
icon compare Compare
icon wishlist Wishlist
Cart
Your shopping cart is empty!
It's never too late to make things right :)

Page 2 - SARMs

Testolone (RAD-140)
Stenabolic (SR-9009)
SARMs mix
S-23
Ostarine (MK-2866)
Myostine (YK-11)
Mastorine (S23)
Ligandrol (LGD-40331)
Ibutamoren (MK-677)
Endurobol (GW501516)
Cardine (GW-0742)
Andarine (S4)
SOU-1870
MK677 10 mg Ortesa Pharmaceuticals
MK677 10 mg Ortesa Pharmaceuticals
Active substance:MK677 Active ingredient, mg:10 Release form:Tablets
In stock
£78.30
Active substance MK677
Active ingredient, mg 10
Release form Tablets
SOU-1850
MK677 10mg Selliza Pharma
MK677 10mg Selliza Pharma
Active substance:MK677 Active ingredient, mg:10 Release form:Tablets
In stock
£94.83
Active substance MK677
Active ingredient, mg 10
Release form Tablets
VIT-PA-5099-EU4
Myostine (YK-11) 5 mg Vital Research
Myostine (YK-11) 5 mg Vital Research
Active substance:SARM Also known as:YK11, YK-11 Blood pressure:Can potentially elevate blood pressure
In stock
£59.16
Active substance SARM
Also known as YK11, YK-11
Blood pressure Can potentially elevate blood pressure
SOU-1882
Myostine 10 mg Ortesa Pharmaceuticals
Myostine 10 mg Ortesa Pharmaceuticals
Active substance:Myostine Active ingredient, mg:10 Release form:Tablets
In stock
£73.08
Active substance Myostine
Active ingredient, mg 10
Release form Tablets
SOU-1857
Myostine 5 mg Selliza Pharma
Myostine 5 mg Selliza Pharma
Active substance:Myostine Active ingredient, mg:5 Release form:Tablets
In stock
£73.95
Active substance Myostine
Active ingredient, mg 5
Release form Tablets
SOU-2002
Ostarin (MK-2866) 20 mg Rich Piana
Ostarin (MK-2866) 20 mg Rich Piana
Active substance:Ostarin (MK-2866) Active ingredient, mg:20 Release form:Capsules
In stock
£60.03
Active substance Ostarin (MK-2866)
Active ingredient, mg 20
Release form Capsules
VIT-PA-5100-EU4
Ostarine (MK-2866) 10 mg Vital Research
Ostarine (MK-2866) 10 mg Vital Research
Active substance:SARM Also known as:Enobosarm, GTx-024 Blood pressure:No significant impact
In stock
£59.16
Active substance SARM
Also known as Enobosarm, GTx-024
Blood pressure No significant impact
SOU-1874
RAD140 10 mg Ortesa Pharmaceuticals
RAD140 10 mg Ortesa Pharmaceuticals
Active substance:RAD140 Active ingredient, mg:10 Release form:Tablets
In stock
£65.25
Active substance RAD140
Active ingredient, mg 10
Release form Tablets
SOU-1856
RAD140 10mg Selliza Pharma
RAD140 10mg Selliza Pharma
Active substance:Testolone ( RAD-140 ) Active ingredient, mg:10 Release form:Tablets
In stock
£86.13
Active substance Testolone ( RAD-140 )
Active ingredient, mg 10
Release form Tablets
VIT-PA-5101-EU4
S-23 10 mg Vital Research
S-23 10 mg Vital Research
Active substance:SARM Also known as:S23, S-23 SARM Blood pressure:Can cause an increase
In stock
£68.73
Active substance SARM
Also known as S23, S-23 SARM
Blood pressure Can cause an increase
SOU-1854
S23 10mg Selliza Pharma
S23 10mg Selliza Pharma
Active substance:S23 Active ingredient, mg:10 Release form:Tablets
In stock
£77.43
Active substance S23
Active ingredient, mg 10
Release form Tablets
SOU-1875
S4 10 mg Ortesa Pharmaceuticals
S4 10 mg Ortesa Pharmaceuticals
Active substance:S4 Active ingredient, mg:10 Release form:Tablets
In stock
£60.03
Active substance S4
Active ingredient, mg 10
Release form Tablets
SOU-1848
S4 25mg Selliza Pharma
S4 25mg Selliza Pharma
Active substance:S4 Active ingredient, mg:25 Release form:Tablets
In stock
£86.13
Active substance S4
Active ingredient, mg 25
Release form Tablets
SOU-1855
SR-9009 10mg Selliza Pharma
SR-9009 10mg Selliza Pharma
Active substance:SR-9009 Active ingredient, mg:10 Release form:Tablets
In stock
£77.43
Active substance SR-9009
Active ingredient, mg 10
Release form Tablets
VIT-PA-5102-EU4
Stenabolic (SR-9009) 8 mg Vital Research
Stenabolic (SR-9009) 8 mg Vital Research
Active substance:SARM Also known as:SR9009, Stenabolic Blood pressure:No significant impact reported
In stock
£59.16
Active substance SARM
Also known as SR9009, Stenabolic
Blood pressure No significant impact reported

Editorial team
Created: 05/11/2025
Jack Clark
Jack Clark Editor